Who We Are Our Products Our Services Our Capabilities Careers News & Insights Contact search LinkedIn Youtube Home Our Products Parenteral Parenteral devices Complex devices, simple patient care The growing prevalence of chronic diseases, along with the evolution of self-administration at home, is driving new ways of administrating parenteral drugs. As injecting a drug means increased risks of use errors and needlestick injuries, self-administration at home translates into a need for safer, easy-to-use and ergonomic devices. We are committed to ensure adherence and user well-being for patients and healthcare professionals providing a comprehensive parenteral product range that matches their need. All Commercially available In development/Research Tailor-made for customers Passive Safety Systems Our premium passive safety device platform, Safe’n’Sound®, helps in preventing needlestick injuries and leveraging patients’ injection experience. It is ergonomically designed for both skilled and inexperienced users. Safe'n'Sound 1ml Safe'n'Sound 2.25 ml Pen platforms Our comprehensive portfolio of own-IP and tailor-made pen injectors help customers to treat a wide range of pathologies. Reusable pens Disposable pens Tailor-made pens and autoinjectors Implanters We developed a portfolio of devices to deliver implants with integrated needlestick protection. As implants can vary a lot, we support your projects and explore design attributes which will increase the user experience such as improved holding and priming, improved motion for implant insertion, etc. Discover More Symbioze Nemera’s wearables: a unique on-body injector offering, to improve patients’ injection experience. Discover More Our services Integrated services from device selection to GMP manufacturing We have developed end-to-end services and expertise in device development, device consulting, and contract manufacturing to complement our diverse portfolio of products to help you through every step of the journey. Discover more Early-stage innovation Our front-end innovation, design research, human factors expertise enhances our capabilities in gaining a full understanding of the patient journey to ensure a successful drug/device combination product. Discover more Testing services for customer formulations Thanks to our cutting-edge laboratory service, our comprehensive test range assures compliant and reliable parenteral drug/device combination products. Discover more FAQ What conditions are Nemera’s parenteral devices used for? Subcutaneous injection is a highly effective route to administer various drug types including small molecules and biologic drugs. Our parenteral device range is used to treat patients with hormonal disorders such as diabetes and infertility. Besides, patients with other chronic conditions such as immune disorders could also benefit safety coupled with an enhanced injection experience from using our devices. What is the difference between passive and active safety system? What is the difference between a reusable and a disposable pen injector? Are all pen injectors used for insulin? In what way does our wearable answer patients’ needs? Our product catalogue Parenteral Download Our pens offering in the press "The added value of a platform approach: pen injector case study" Discover the article More about Nemera Knowledge Hub Cutting-edge insights, resources, press articles, and webinars to learn more about the holistic ecosystem of drug delivery device solutions. Discover more Who we are We design and manufacture devices that maximize treatment efficacy and partner with our customers in their device strategies, to ultimately bring high-quality and safe treatment solutions to patients. Discover more Get in touch Get in touch to find out more about us, our solutions and what we can do for you. If you’re looking for job opportunities, please visit: Join Our Team First Name*: Last Name*: Company Name*: Job Title*: State: Country*: Please select... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao, People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe Email*: Phone: Main Interest*: Please select... Our Services Our Products Other Channel (how did you hear about us?)*: Please select... Search Engine Social Media Website Exhibitions Press Word of Mouth Third party network Other Message*: Your personal data is intended for Nemera and its subsidiaries to process your request for information. You have rights over your personal data, such as the right to access, erase and object. For more information, see our Privacy Policy. * Required fields. LinkedIn Twitter Youtube Who We Are Privacy Policy Cookies policy Legal Policy 20 Avenue de la Gare 38290 La Verpillière - France T. +33 4 74 94 06 54 © 2021 Nemera. Website developed by Illustrate Digital